Showing results (231-240 of 254) with videos related to
Sort By:
Pageof 26
Journal of Medicinal Chemistry|October 30, 1992
Conformationally constrained tachykinin analogues: potent and highly selective neurokinin NK-2 receptor agonistsM J Deal, R M Hagan, S J Ireland, et al.Obesity Research|May 1, 1997
Dietary and exercise interventions for juvenile obesity: long-term effect of behavioral and public health modelsW G Johnson, L K Hinkle, R E Carr, et al.Medicine and Science in Sports|January 1, 1976
Effects of dianabol and high-intensity sprint training on body composition of ratsR C Hickson, W W Heusner, W D Huss, et al.British Journal of Pharmacology|January 1, 1994
Cardiovascular effects of GR117289, a novel angiotensin AT1 receptor antagonistA Hilditch, A A Hunt, C J Gardner, et al.Journal of Medicinal Chemistry|September 16, 1994
Bromobenzofuran-based non-peptide antagonists of angiotensin II: GR138950, a potent antihypertensive agent with high oral bioavailabilityD B Judd, M D Dowle, D Middlemiss, et al.British Journal of Pharmacology|December 1, 1992
Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonistM J Robertson, J C Barnes, G M Drew, et al.Journal of Medicinal Chemistry|July 10, 1992
Highly potent and selective heptapeptide antagonists of the neurokinin NK-2 receptorA B McElroy, S P Clegg, M J Deal, et al.The Journal of Biological Chemistry|June 15, 1992
Squalestatin 1, a potent inhibitor of squalene synthase, which lowers serum cholesterol in vivoA Baxter, B J Fitzgerald, J L Hutson, et al.Archives of Biochemistry and Biophysics|May 15, 1992
Effect of riboflavin-binding protein deficiency on riboflavin metabolism in the laying henH B White, E F Nuwaysir, S P Komara, et al.Journal of Virological Methods|September 17, 1999
ELISA for IgG-class antibody to hepatitis E virus based on a highly conserved, conformational epitope expressed in Escherichia coliD A Anderson, F Li, M Riddell, et al.Pageof 26